Type 3 Von Willebrand International Registries Inhibitor Prospective Study

CompletedOBSERVATIONAL
Enrollment

265

Participants

Timeline

Start Date

November 5, 2012

Primary Completion Date

March 28, 2023

Study Completion Date

April 17, 2023

Conditions
Type 3 Von Willebrand's Disease
Interventions
DRUG

Von Willebrand Factor

Replacement therapy with plasma-derived and/or recombinant VWF concentrates on-demand or under prophylaxis therapeutic scheme.

Trial Locations (25)

1097

St. Istvan & St. Laszlo Hospital of Budapest - Hematology and Stem Cell Transplantation, Budapest

2333

Leiden University Medical Center - Department of Hematology - Hemostasis and Thrombosis Center, Leiden

3015

Erasmus Medical Center - Department of Hematology, Rotterdam

15006

Complejo Hospitalario Universitario de A Coruña - Servicio de Hematología y Hemoterapia, A Coruña

20122

Centro Emofilia e Trombosi - Fondazione Angelo Bianchi Bonomi - IRCCS Ospedale Ca' Granda - Dip. di Medicina Interna - Università degli Studi di Milano, Milan

20246

University Children's Hospital - Department of Pediatric Hematology and Oncology, Hamburg

30625

Department of Haematology, Haemostasis, Oncology and Stem Cell Transplantation - Hannover Medical School - Haemophilia Care Centre, Hanover

36100

Dipartimento di Terapie Cellulari ed Ematologia - Centro Malattie Emorragiche e Trombotiche - Ospedale San Bortolo, Vicenza

44093

Centre Régional de Traitement de l'Hémophilie - Laboratoire d'Hématologie, Nantes

50141

Azienda Ospedaliera Universitaria Careggi - Agenzia per l'Emofilia - Centro di Riferimento Coagulopatie Congenite, Florence

53127

University Clinic Bonn - Institute of Experimental Haematology & Transfusion Medicine, Bonn

59037

Institut d'Hématologie - Hôpital Cardiologique - University of Lille - Haematology Department, Lille

70124

Azienda Ospedaliera Policlinico Consorziale di Bari - Unità Operativa Semplice di Emostasi e Trombosi, Bari

FIN-00029 HUS

Helsinki University Central Hospital, Department Internal Medicine, Coagulation Disorders, at Haematology and Laboratory Services, Helsinki

Unknown

Ahvaz Jundishpur University of Medical Sciences - Research Center for Thalassemia & Hemoglobinopathy - Division of Hematology & Oncology, Ahvāz

Seid-ol-Shohada Hospital - Hemophilia Center - Esfahan University of Medical Science, Isfahan

Hemophilia- Thalassaemia Center of Mashhad (Sarvar Clinic) - Mashad University of Medical Science, Mashhad

Nemazee Hospital Hemophilia Center - Shiraz University of Medical Science, Shiraz

Iranian Hemophilia Comprehensive Treatment Centre - Iranian Hemophilia Society, Tehran

Mofid Comprehensive Care Centre for Children with Hemophilia - Shahid Beheshti University of Medical Science, Tehran

Thrombosis Hemostasis Research Center - Vali-Asr Hospital - Emam Khmeini Complex Hospital - Tehran University of Medical Science, Tehran

00161

"Dipartimento di Biotecnologie Cellulari ed Ematologia - Università Sapienza di Roma - Policlinico Umberto I", Roma

08035

Hospital Universitari General Vall d'Hebron - Unidad de Hemofilia, Barcelona

205 02

Lund University - Centre for Thrombosis and Haemostasis - Skane University Hospital, Malmo

M13 9WL

Central Manchester University Hospital NHS Foundation Trust - Manchester Royal Infirmary - Manchester Royal Eye Hospital, Manchester

All Listed Sponsors
collaborator

Sintesi Research Srl

INDUSTRY

lead

Fondazione Angelo Bianchi Bonomi

OTHER

NCT02460458 - Type 3 Von Willebrand International Registries Inhibitor Prospective Study | Biotech Hunter | Biotech Hunter